Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy

Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy

Guardado en:
Detalles Bibliográficos
Autores principales: Briony Adams, Alec Beaney
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Procalcitonin
Renal replacement therapy
COVID-19
Continuous venovenous haemofiltration
Bacterial
Antimicrobial
Microbiology
QR1-502
Acceso en línea:https://doaj.org/article/80209970dfdd4a6abe1e1bd1d4d8e4f6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:80209970dfdd4a6abe1e1bd1d4d8e4f6
record_format dspace
spelling oai:doaj.org-article:80209970dfdd4a6abe1e1bd1d4d8e4f62021-11-30T04:15:55ZInterpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy2213-716510.1016/j.jgar.2021.09.014https://doaj.org/article/80209970dfdd4a6abe1e1bd1d4d8e4f62021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S221371652100237Xhttps://doaj.org/toc/2213-7165Briony AdamsAlec BeaneyElsevierarticleProcalcitoninRenal replacement therapyCOVID-19Continuous venovenous haemofiltrationBacterialAntimicrobialMicrobiologyQR1-502ENJournal of Global Antimicrobial Resistance, Vol 27, Iss , Pp 324-325 (2021)
institution DOAJ
collection DOAJ
language EN
topic Procalcitonin
Renal replacement therapy
COVID-19
Continuous venovenous haemofiltration
Bacterial
Antimicrobial
Microbiology
QR1-502
spellingShingle Procalcitonin
Renal replacement therapy
COVID-19
Continuous venovenous haemofiltration
Bacterial
Antimicrobial
Microbiology
QR1-502
Briony Adams
Alec Beaney
Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy
format article
author Briony Adams
Alec Beaney
author_facet Briony Adams
Alec Beaney
author_sort Briony Adams
title Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy
title_short Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy
title_full Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy
title_fullStr Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy
title_full_unstemmed Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy
title_sort interpreting serum procalcitonin in covid-19 patients undergoing renal replacement therapy
publisher Elsevier
publishDate 2021
url https://doaj.org/article/80209970dfdd4a6abe1e1bd1d4d8e4f6
work_keys_str_mv AT brionyadams interpretingserumprocalcitoninincovid19patientsundergoingrenalreplacementtherapy
AT alecbeaney interpretingserumprocalcitoninincovid19patientsundergoingrenalreplacementtherapy
_version_ 1718406814457921536

Ejemplares similares